0001127602-18-037522.txt : 20181231 0001127602-18-037522.hdr.sgml : 20181231 20181231083925 ACCESSION NUMBER: 0001127602-18-037522 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151008 FILED AS OF DATE: 20181231 DATE AS OF CHANGE: 20181231 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Faleck Herbert J CENTRAL INDEX KEY: 0001652994 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37568 FILM NUMBER: 181258685 MAIL ADDRESS: STREET 1: 200 CONNELL DRIVE STREET 2: SUITE 1600 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edge Therapeutics, Inc. CENTRAL INDEX KEY: 0001472091 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264231384 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 CONNELL DRIVE STREET 2: SUITE 4000 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 BUSINESS PHONE: 800-208-3343 MAIL ADDRESS: STREET 1: 300 CONNELL DRIVE STREET 2: SUITE 4000 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 4/A 1 form4a.xml PRIMARY DOCUMENT X0306 4/A 2015-10-08 2015-10-08 1 0001472091 Edge Therapeutics, Inc. EDGE 0001652994 Faleck Herbert J 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922 1 Chief Medical Officer Common Stock 32061.25 I 401(K) Plan Reflects periodic contributions to the issuer's common stock fund in the issuer's 401(K) Plan as of December 28, 2018. This amendment is being filed to include these shares of the issuer's common stock that were omitted in the prior report. /s/ Herbert J. Faleck, Reporting Person 2018-12-31